Homocysteine, B vitamins, and coronary artery disease (Q33843655)

29 July 2017

1 reference

title

Homocysteine, B vitamins, and coronary artery disease (English)

1 reference

29 July 2017

0 references

coronary artery disease

1 reference

Seshadri N

1

1 reference

PubMed ID

10685136

29 July 2017

Robinson K

series ordinal

2

1 reference

29 July 2017

1 January 2000

1 reference

Medical Clinics of North America

29 July 2017

1 reference

29 July 2017

84

1 reference

29 July 2017

1

1 reference

29 July 2017

215-37, x

1 reference

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Serum total homocysteine and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Vitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin's hypolipidemic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

7 January 2021

Nitric oxide 9 years on

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Tamoxifen reduces plasma homocysteine levels in healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Serum homocysteine increases after therapy with fenofibrate or bezafibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

The identification of homocystine in the urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocystinemia. Vascular injury and arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Kinetics and distribution of 111Indium-labeled platelets in patients with homocystinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

The redox status of aminothiols as a clue to homocysteine-induced vascular damage?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Low vitamin B6 status in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Biochemistry and molecular genetics of cystathionine beta-synthase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocystinuria due to cystathionine synthase deficiency: the metabolism of L-methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine and vascular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine and coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma total homocysteine levels in hyperthyroid and hypothyroid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma homocysteine levels and mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Folic acid fortification of the food supply. Potential benefits and risks for the elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Methionine loading test is necessary for detection of hyperhomocysteinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

No net renal extraction of homocysteine in fasting humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A prospective study of plasma homocyst(e)ine and risk of ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

Role of endothelium in thrombosis and hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970215-7

10.1016/S0025-7125(05)70215-7

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10685136